Wide variation in colorectal cancer rates after colonoscopies in England

Substantial variation exists between colonoscopy providers in rates of colorectal cancer up to three years after colonoscopy in England, according to a study. ‘Variation in post-colonoscopy colorectal cancer across colonoscopy providers in the English National Health Service: population-based cohort study’(1), published by The BMJ.

Medtronic launches the first artificial intelligence system for colonoscopy

Medtronic has announced the launch of GI Genius intelligent endoscopy module at UEG Week in Barcelona, Spain. The GI Genius module is the first system worldwide using artificial intelligence to detect colorectal polyps. It provides physicians with a powerful new solution in the fight against colorectal cancer.

Ulcerative Colitis: vedolizumab out performs adalimumab for clinical remission and endoscopic improvement

The IKBFU center for clinical research scientists have participated in the international VARSITY clinical research study, the world's first study aimed at finding the most effective drug among anti-inflammatory drugs for the treatment of ulcerative colitis. The results, ‘Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis’, were published in The New England Journal of Medicine.

Positive outcomes for patients 85 years and older after colectomies

Results from a preliminary research study examining the outcomes of colectomy patients over 85 has revealed that the vast majority of were still alive in the short-term after undergoing the procedure to remove a portion of the colon for stage II and III colon cancer. Researchers presented their findings at the American College of Surgeons Clinical Congress 2019.